Vaxcyte, Inc. (PCVX)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

353 HATCH DR FOSTER CITY, CA 94404

Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The Company’s cell-free protein synthesis platform, comprising the XpressCFTM platform, exclusively licensed from Sutro Biopharma, Inc., together with Vaxcyte’s proprietary know-how, enables the design and production of protein carriers and antigens, the critical building blocks of vaccines, in ways that the Company believes conventional vaccine technologies currently cannot. Vaxcyte’s lead vaccine candidate, VAX-24, is a preclinical, 24-valent broad-spectrum pneumococcal conjugate vaccine (PCV) being developed for the prevention of invasive pneumococcal disease (IPD). Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of at least 30 strains, including newly emerging strains responsible for IPD and antibiotic resistance; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease by targeting the keystone pathogen responsible for this chronic, oral inflammatory disease.

Data as of 2021-05-08 12:10:07 -0400
Market Cap905.893 Million Shares Outstanding51.355 Million Avg 30-day Volume237.306 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-8.22 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low58.48 / 16.73 Next Earnings Date2021-05-12 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from PCVX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 5 6 -16.67% 1 (0.06%) 2 (0.12%) -50.0%
Funds Holding: 83 60 38.33% 23 (1.38%) 18 (1.12%) 27.78%
13F shares: 42.247 Million 37.742 Million 11.94% 10.451 Million 11.124 Million -6.05%
% Ownership 82.9183 74.0768 11.94% 20.5123 21.8329 -6.05%
New Positions: 28 34 -17.65% 7 7 0.0%
Increased Positions 28 7 300.0% 7 2 250.0%
Closed Positions 5 12 -58.33% 2 9 -77.78%
Reduced Positions 14 11 27.27% 5 6 -16.67%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding PCVX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PCVX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

22.3 Thousand total shares from 5 transactions

Exercise Derivative Conversion (M)

25 Thousand total shares from 4 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FAIRMAN JEFF VP, RESEARCH

  • Officer
484,264 2021-04-22 6

SAUER PAUL SVP PROCESS DEV, MANUFACTURING

  • Officer
121,156 2021-04-05 5

PICKERING GRANT CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
310,000 2021-04-01 6

WRIGHT-MITCHELL JANE GENERAL COUNSEL

  • Officer
93,340 2021-04-01 4

WASSIL JIM CHIEF OPERATING OFFICER

  • Officer
93,340 2021-04-01 3

GUGGENHIME ANDREW PRESIDENT AND CFO

  • Officer
145,000 2021-04-01 1

HOPFNER ROBERT LORNE

  • Director
1,405,418 2021-02-08 10

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
5,074,574 2020-12-15 1

NEWELL WILLIAM J

  • Director
66,684 2020-12-09 2

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
5,001,593 2020-10-07 3

EMSTER KURT VON

  • Director
4,168,718 2020-06-16 3

HERON PATRICK J

  • Director
2,309,554 2020-06-16 2

ABINGWORTH LLP

  • 10% Owner
0 2020-06-11 2

LUKATCH HEATH

  • Director
0 2020-06-11 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FAIRMAN JEFF - Officer VP, RESEARCH

2021-04-23 19:31:24 -0400 2021-04-22 M 2,793 d 88,836 direct

FAIRMAN JEFF - Officer VP, RESEARCH

2021-04-23 19:31:24 -0400 2021-04-22 M 2,793 $1.79 a 4,201 direct -3.608 -9.8489 0.0 1 -9.8489 6

SAUER PAUL - Officer SVP PROCESS DEV, MANUFACTURING

2021-04-07 21:17:52 -0400 2021-04-05 J 21,871 d 48,197 direct

SAUER PAUL - Officer SVP PROCESS DEV, MANUFACTURING

2021-04-07 21:17:52 -0400 2021-04-05 J 38,308 d 39,591 direct -2.6012 -6.1175 0.0 1 -7.2736 4

SAUER PAUL - Officer SVP PROCESS DEV, MANUFACTURING

2021-04-07 21:17:52 -0400 2021-04-05 J 14,253 d 7,173 direct

SAUER PAUL - Officer SVP PROCESS DEV, MANUFACTURING

2021-04-07 21:17:52 -0400 2021-04-05 J 7,611 d 22,027 direct

SAUER PAUL - Officer SVP PROCESS DEV, MANUFACTURING

2021-04-07 21:17:52 -0400 2021-04-05 J 4,168 d 4,168 direct

WASSIL JIM - Officer CHIEF OPERATING OFFICER

2021-04-06 20:04:51 -0400 2021-04-01 A 93,340 a 93,340 direct

PICKERING GRANT - Director - Officer CHIEF EXECUTIVE OFFICER

2021-04-06 20:01:19 -0400 2021-04-01 A 310,000 a 310,000 direct

FAIRMAN JEFF - Officer VP, RESEARCH

2021-04-06 20:10:12 -0400 2021-04-01 A 40,000 a 40,000 direct

SAUER PAUL - Officer SVP PROCESS DEV, MANUFACTURING

2021-04-06 20:06:46 -0400 2021-04-01 A 40,000 a 40,000 direct

WRIGHT-MITCHELL JANE - Officer GENERAL COUNSEL

2021-04-06 20:08:10 -0400 2021-04-01 A 93,340 a 93,340 direct

GUGGENHIME ANDREW - Officer PRESIDENT AND CFO

2021-04-06 20:02:40 -0400 2021-04-01 A 145,000 a 145,000 direct

FAIRMAN JEFF - Officer VP, RESEARCH

2021-03-29 19:18:35 -0400 2021-03-26 S 3,389 $23.64 d 2,769 direct yes 5.8414 17.0954 0.0536 19.1854 4 -11.8435 29

FAIRMAN JEFF - Officer VP, RESEARCH

2021-03-29 19:18:35 -0400 2021-03-26 M 4,750 d 7,259 direct

FAIRMAN JEFF - Officer VP, RESEARCH

2021-03-29 19:18:35 -0400 2021-03-26 M 4,750 $0.04 a 6,158 direct 5.8414 17.0954 0.0536 19.1854 4 -11.8435 29

FAIRMAN JEFF - Officer VP, RESEARCH

2021-03-29 19:18:35 -0400 2021-03-26 S 1,361 $24.48 d 1,408 direct yes 5.8414 17.0954 0.0536 19.1854 4 -11.8435 29

PICKERING GRANT - Director - Officer PRESIDENT & CEO

2021-03-23 20:49:43 -0400 2021-03-19 S 15,000 $25.77 d 578,691 direct yes 11.3987 -10.3088 -21.3442 11.3987 2 -21.5259 29

PICKERING GRANT - Director - Officer PRESIDENT & CEO

2021-03-23 20:49:43 -0400 2021-03-19 M 15,000 $1.79 a 593,691 direct 11.3987 -10.3088 -21.3442 11.3987 2 -21.5259 29

PICKERING GRANT - Director - Officer PRESIDENT & CEO

2021-03-23 20:49:43 -0400 2021-03-19 M 15,000 d 448,815 direct

WRIGHT-MITCHELL JANE - Officer GENERAL COUNSEL

2021-03-17 16:55:59 -0400 2021-03-15 M 2,500 $2.03 a 4,062 direct -1.1669 -4.5897 -27.7713 0.0 1 -32.0498 23

WRIGHT-MITCHELL JANE - Officer GENERAL COUNSEL

2021-03-17 16:55:59 -0400 2021-03-15 S 1,487 $27.49 d 1,562 direct yes -1.1669 -4.5897 -27.7713 0.0 1 -32.0498 23

WRIGHT-MITCHELL JANE - Officer GENERAL COUNSEL

2021-03-17 16:55:59 -0400 2021-03-15 S 1,013 $27.01 d 3,049 direct yes -1.1669 -4.5897 -27.7713 0.0 1 -32.0498 23

WRIGHT-MITCHELL JANE - Officer GENERAL COUNSEL

2021-03-17 16:55:59 -0400 2021-03-15 M 2,500 d 199,968 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VAXCYTE INC PCVX 2021-05-14 16:45:03 UTC -0.5247 0.5747 25000
VAXCYTE INC PCVX 2021-05-14 16:15:03 UTC -0.5247 0.5747 15000
VAXCYTE INC PCVX 2021-05-14 15:45:03 UTC -0.5247 0.5747 15000
VAXCYTE INC PCVX 2021-05-14 15:15:02 UTC -0.5247 0.5747 15000
VAXCYTE INC PCVX 2021-05-14 14:45:04 UTC -0.5244 0.5744 15000
VAXCYTE INC PCVX 2021-05-14 14:15:03 UTC -0.5244 0.5744 15000
VAXCYTE INC PCVX 2021-05-14 13:45:03 UTC -0.5244 0.5744 15000
VAXCYTE INC PCVX 2021-05-14 13:15:03 UTC -0.5244 0.5744 15000
VAXCYTE INC PCVX 2021-05-14 12:45:03 UTC -0.5244 0.5744 15000
VAXCYTE INC PCVX 2021-05-13 22:15:03 UTC -0.5244 0.5744 90000
VAXCYTE INC PCVX 2021-05-13 21:45:03 UTC -0.5244 0.5744 90000
VAXCYTE INC PCVX 2021-05-13 21:15:03 UTC -0.5244 0.5744 90000
VAXCYTE INC PCVX 2021-05-13 20:45:04 UTC -0.5242 0.5742 90000
VAXCYTE INC PCVX 2021-05-13 20:15:04 UTC -0.5242 0.5742 90000
VAXCYTE INC PCVX 2021-05-13 19:45:03 UTC -0.5242 0.5742 90000
VAXCYTE INC PCVX 2021-05-13 19:15:02 UTC -0.5242 0.5742 90000
VAXCYTE INC PCVX 2021-05-13 18:45:02 UTC -0.5162 0.5662 90000
VAXCYTE INC PCVX 2021-05-13 18:15:03 UTC -0.5162 0.5662 90000
VAXCYTE INC PCVX 2021-05-13 17:45:03 UTC -0.5162 0.5662 90000
VAXCYTE INC PCVX 2021-05-13 17:15:03 UTC -0.5162 0.5662 90000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments